A Year In, 1st Patient To Get Gene-Editing For Sickle Cell Disease Is Thriving

Since receiving a landmark treatment with the gene-editing tool CRISPR, a sickle cell patient has the strength to care for herself and her children — while navigating the pandemic.

A Year In, 1st Patient To Get Gene-Editing For Sickle Cell Disease Is Thriving Since receiving a landmark treatment with the gene-editing tool CRISPR, a sickle cell patient has the strength to care for herself and her children — while navigating the pandemic. Read More RELATED STORIES Researchers Hope New CRISPR Technique Could Speed Up Coronavirus Testing You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002 Unsubscribe  |  Privacy Policy